1 Morgan Stanley, Could Obesity Drugs Take a Bite Out of the Food Industry, 2023 2 Morgan Stanley, 2023 3 The Food Institute, 2024 4 Nestle, First-to-market Vital Pursuit Hits Shelves Nationwide, 2024 5 Grocery Dive, How GLP-1s Could Reshape the Grocery Store, 2025 6 MediaRadar, Weight Loss, Diabetes Drug Ad Spending Tops $1B, 2024 7 McKinsey, What are GLP-1 Medications?, 2025 8 JP Morgan Research, The Increase in Appetite for Obesity Drugs, 2023 9 Cornell University, The No-Hunger Games: How GLP-1 Medication Adoption is Changing Consumer Food Demand, 2024
By enhancing glutathione levels, IVs and injections can aid in the removal of toxins, heavy metals, and harmful substances from the body, promoting overall detoxification and improved cellular function
Situations where oral administration is not feasible (e.g., anorexia, nausea, pre-op, GI absorption issues)
Hypokalemia: Rapid treatment of severe anaemia with vitamin B12 could cause low potassium levels (hypokalemia), necessitating monitoring